Pharmaceutical Division
The Pharmaceutical Division of Lampugnani Farmaceutici S.p.A., founded in 1880, is one of the longest-established companies in the Italian pharmaceutical industry.
The company operates in both domestic and international markets through a dynamic, flexible, and efficient commercial organization, capable of meeting the evolving demands of the pharmaceutical sector while remaining true to the values that have shaped its history.
A continuous commitment to research and innovation enables Lampugnani Farmaceutici S.p.A. to offer a comprehensive portfolio of pharmaceutical products covering the major therapeutic areas and meeting the needs of physicians, pharmacists, and patients.
Lampugnani Farmaceutici S.p.A. is also active in the food supplements market, offering a range of products developed according to rigorous scientific standards to meet a variety of nutritional needs and support individual well-being.
Questa versione utilizza un inglese naturale e professionale, evitando traduzioni letterali e adottando la terminologia normalmente impiegata dalle aziende farmaceutiche internazionali.
PRODUCTS
UROLOGY
RADIOTHERAPY
GASTROENTEROLOGY
NEUROLOGY
GYNECOLOGY
OTOLARYNGOLOGY
PROCTOLOGY
GENERAL PRACTICE
Pharmacovigilance
Pharmacovigilance is a set of activities aimed at continuously monitoring all safety information and to ensure, for all medicinal products on the market, a positive risk/benefit ratio.
Lampugnani Farmaceutici S.p.A. provides the pharmacovigilance email farmacovigilanza@lampugnanifarmaceutici.it and the telephone number +39 333.7336518 available 24 h, related to collect all the spontaneous suspected adverse reactions reports.
The notification of suspected adverse reactions reports may be carried out not only by the health care professionist but also by ordinary citizens, using appropriate sheets available on the AIFA website.
